H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Price:
17.19
CNY
0.88%
Market Cap:
¥14.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
CN |
|
S
|
Shanxi Coal International Energy Group Co Ltd
SSE:600546
|
CN |
|
O
|
OTP Bank Nyrt
BET:OTP
|
HU |
|
I
|
Inbest Prime I Inmuebles SOCIMI SA
MAD:YINB1
|
ES |
|
B
|
Bank of Hangzhou Co Ltd
SSE:600926
|
CN |
|
Guangzhou Hexin Instrument Co Ltd
SSE:688622
|
CN |
|
Wuhan Raycus Fiber Laser Technologies Co Ltd
SZSE:300747
|
CN |
|
O
|
OMH SCIENCE Group Co Ltd
SZSE:300486
|
CN |
Balance Sheet
Balance Sheet Decomposition
Huaxia Eye Hospital Group Co Ltd
Huaxia Eye Hospital Group Co Ltd
Balance Sheet Decomposition is not available for
Huaxia Eye Hospital Group Co Ltd
Huaxia Eye Hospital Group Co Ltd
Balance Sheet
Huaxia Eye Hospital Group Co Ltd
Huaxia Eye Hospital Group Co Ltd
Currency: CNY
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
346
|
503
|
953
|
1 337
|
3 903
|
3 470
|
|
| Cash |
346
|
503
|
953
|
1 337
|
3 903
|
3 470
|
|
| Short-Term Investments |
0
|
0
|
0
|
2 798
|
322
|
670
|
|
| Total Receivables |
206
|
179
|
220
|
242
|
378
|
359
|
|
| Accounts Receivables |
174
|
153
|
188
|
195
|
323
|
286
|
|
| Other Receivables |
31
|
25
|
32
|
47
|
55
|
73
|
|
| Inventory |
87
|
107
|
126
|
157
|
207
|
161
|
|
| Other Current Assets |
50
|
49
|
40
|
82
|
81
|
129
|
|
| Total Current Assets |
688
|
838
|
1 338
|
4 617
|
4 892
|
4 789
|
|
| PP&E Net |
889
|
783
|
1 338
|
1 336
|
1 476
|
1 785
|
|
| PP&E Gross |
889
|
783
|
1 338
|
1 336
|
1 476
|
1 785
|
|
| Accumulated Depreciation |
501
|
606
|
850
|
1 070
|
1 255
|
1 493
|
|
| Intangible Assets |
70
|
70
|
64
|
112
|
104
|
111
|
|
| Goodwill |
51
|
51
|
51
|
60
|
173
|
546
|
|
| Note Receivable |
14
|
14
|
46
|
66
|
67
|
72
|
|
| Long-Term Investments |
64
|
120
|
134
|
141
|
358
|
249
|
|
| Other Long-Term Assets |
339
|
287
|
250
|
405
|
309
|
372
|
|
| Other Assets |
51
|
51
|
51
|
60
|
173
|
546
|
|
| Total Assets |
2 114
N/A
|
2 162
+2%
|
3 220
+49%
|
6 736
+109%
|
7 379
+10%
|
7 924
+7%
|
|
| Liabilities | |||||||
| Accounts Payable |
269
|
262
|
202
|
208
|
264
|
303
|
|
| Accrued Liabilities |
202
|
214
|
228
|
227
|
266
|
283
|
|
| Short-Term Debt |
35
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
25
|
0
|
113
|
97
|
117
|
143
|
|
| Other Current Liabilities |
220
|
193
|
241
|
257
|
357
|
301
|
|
| Total Current Liabilities |
751
|
669
|
785
|
790
|
1 004
|
1 030
|
|
| Long-Term Debt |
207
|
0
|
545
|
637
|
632
|
842
|
|
| Deferred Income Tax |
9
|
15
|
18
|
171
|
18
|
21
|
|
| Minority Interest |
37
|
32
|
17
|
13
|
62
|
229
|
|
| Other Liabilities |
25
|
27
|
23
|
8
|
7
|
8
|
|
| Total Liabilities |
1 029
N/A
|
743
-28%
|
1 388
+87%
|
1 619
+17%
|
1 723
+6%
|
2 130
+24%
|
|
| Equity | |||||||
| Common Stock |
500
|
500
|
500
|
560
|
840
|
840
|
|
| Retained Earnings |
332
|
666
|
1 121
|
1 635
|
2 181
|
2 518
|
|
| Additional Paid In Capital |
253
|
253
|
211
|
2 918
|
2 636
|
2 639
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
3
|
2
|
2
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
200
|
|
| Total Equity |
1 085
N/A
|
1 419
+31%
|
1 832
+29%
|
5 117
+179%
|
5 655
+11%
|
5 794
+2%
|
|
| Total Liabilities & Equity |
2 114
N/A
|
2 162
+2%
|
3 220
+49%
|
6 736
+109%
|
7 379
+10%
|
7 924
+7%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
560
|
840
|
840
|
840
|
840
|
833
|
|
Switch to:
Switch to:
See Also
Discover More
